ClinicalTrials.gg
Not yet recruitingNCT07832773FOUR-ICUUpdated Sep 22, 2026

FOUR-Based Modification of ICU Severity Scores

An observational study in ICU Mortality (Survival Rate), sponsored by Al-Nahrain University. Not yet recruiting at 1 site in Iraq. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Al-Nahrain University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
16 Years and older
Sex
All
01

Study summary

The goal of this observational study is to evaluate whether the Full Outline of UnResponsiveness (FOUR) score can replace the Glasgow Coma Scale (GCS) as the neurologic component of established intensive care unit (ICU) severity scoring systems and to derive and validate modified APACHE, SAPS, MODS, LODS, and SOFA models incorporating the FOUR score in critically ill adult patients.

The main questions it aims to answer are:

Does replacing the GCS with the FOUR score provide comparable or improved discrimination for in-hospital mortality across established ICU severity scoring systems? Can FOUR-based modifications of APACHE, SAPS, MODS, LODS, and SOFA be successfully derived and validated with adequate discrimination, calibration, and overall predictive performance? Do the modified FOUR-based models demonstrate predictive performance comparable to or different from the corresponding original GCS-based models?

Researchers will compare the performance of the modified FOUR-based models with their original GCS-based counterparts to determine whether substitution of the FOUR score provides valid and clinically useful risk prediction in critically ill adults.

Participants will not receive an experimental intervention. Data routinely collected during ICU care will be used to:

Calculate the original GCS-based APACHE, SAPS, MODS, LODS, and SOFA scores. Replace the GCS component with the FOUR score and derive the corresponding modified models.

Evaluate and validate the predictive performance of the original and modified models using measures of discrimination, calibration, and overall predictive accuracy.

Read the detailed description

Intensive care units (ICUs) are highly complex, resource and technology intensive settings. During the 1970s and 1980s, increasing intensive care costs and poor outcomes among patients with multiple organ failure created a need for tools to measure illness severity and patient outcomes. Intensive care unit mortality varies considerably worldwide, with rates of 16.2% in large international study and 19.1% in a European cohort study, while higher mortality was reported in developing countries, Ethiopia (39.06%) and Iraq (29.8%).

The Glasgow Coma Scale (GCS) assesses impaired consciousness using eye opening, verbal, and motor responses and is widely used for assessment, triage, monitoring, and communication among healthcare professionals. It has several limitations, verbal component cannot be assessed reliably in patients who are intubated, pharmacologically sedated, or unable to speak, limiting the use of the total score for prognosis. Also has limitation in evaluation patients with concomitant head and spinal cord injury. Drug and alcohol intoxication can also affect GCS assessment and should be considered when interpreting scores. In addition, Aphasia, paralysis, neuromuscular weakness, and spinal injuries may impair verbal or motor responses independently of consciousness, while painful stimuli can complicate scoring in polytrauma patients. Its reliability depends on assessor training, the patient's consciousness level, and the type of stimulus used.

The Full Outline of UnResponsiveness (FOUR) score consisting of four components: eye response, motor response, brainstem reflexes, and respiration, with each component assigned a maximum score of 4. It showed excellent interrater reliability (weighted kappa = 0.82), and provide greater neurological detail and identification of severe impairment than GCS. In non-traumatic patients, FOUR score showed better mortality discrimination than GCS (AUROC 0.799 vs. 0.731), and offers advantages in intubated patients because it evaluates brainstem reflexes and respiratory patterns. FOUR also showed better mortality prediction than GCS in traumatic brain injury, neurosurgical, and acute brain-injury patients, with AUROC values of 0.93 vs. 0.89, 0.768 vs. 0.699, and 0.835 vs. 0.772, respectively.

The Acute Physiology and Chronic Health Evaluation (APACHE) assess risk of in-hospital by using pre-admission health status and 34 physiological variables collected during the first 24 hours of ICU admission. The Acute Physiology and Chronic Health Evaluation II (APACHE II) uses 12 physiological variables, along with age and previous health status, to calculate a score from 0-71, with higher scores indicating greater illness severity and mortality risk. APACHE III incorporated over 100 variables, while APACHE IV added further clinical factors and enabled prediction of hospital mortality and ICU length of stay.

The Simplified Acute Physiology Score (SAPS) includes14 physiological variables collected during the first 24 hours of ICU admission to provides a simple measure of the risk of death among critically ill patients. The Simplified Acute Physiology Score II (SAPS II) provide an objective assessment of illness severity and an estimate of hospital mortality among critically ill patients. SAPS II involve 17 variables, including 12 physiological measurements, age, type of ICU admission, and three underlying disease conditions: acquired immunodeficiency syndrome, metastatic cancer, and hematologic malignancy. SAPS 3, incorporated 20 variables and provided region-specific mortality prediction for international use.

The Multiple Organ Dysfunction Score (MODS) assesses six organ systems using PaO₂/FiO₂ ratio, creatinine, bilirubin, platelet count, Glasgow Coma Scale, and pressure-adjusted heart rate. Each variable is scored from 0-4, producing a total score of 0-24, with higher values associated with increased ICU mortality.

The Sequential Organ Failure Assessment (SOFA) assesses organ dysfunction and illness severity, particularly in sepsis. It evalutes six organ systems: respiratory function using the PaO₂/FiO₂ ratio, coagulation using platelet count, liver function using serum bilirubin, cardiovascular function according to mean arterial pressure and vasopressor requirements, central nervous system function using the Glasgow Coma Scale, and renal function using serum creatinine or urine output. The worst daily values are scored from 0-4, giving a total of 0-24, with higher scores indicating greater organ dysfunction. SOFA is practical for bedside use and is mainly used to quantify organ dysfunction, evaluate treatment effects, and monitor progression, with higher scores are associated with increased mortality in sepsis.

The Logistic Organ Dysfunction System (LODS) was derived from 12 countries. It evaluates six organ systems using variables related to neurologic, cardiovascular, renal, pulmonary, hematologic, and hepatic function, producing a score from 0-22. It showed good discrimination, with AUROC values of 0.843 in the development sample and 0.850 in the validation sample. It can also accurately describe the progression of illness when applied on a daily basis.

Trauma severity scoring systems help assess injury severity, guide triage, and predict patient outcomes. It can be divided into anatomical, physiological, and combined scores each with advantages and disadvantages. Anatomical scores describe the injuries recorded by clinical examination, imaging, surgery, or autopsy. While Physiologic Scores describe changes due to a trauma and translated by changes in vital signs and consciousness. Combining anatomical and physiological scores may provide better prediction of mortality in severely injured ICU patients.

The Trauma and Injury Severity Score (TRISS) combines Revised Trauma Score, Injury Severity Score, and patient age, to improve prediction of trauma outcomes. The Rapid Emergency Medicine Score (REMS) is a physiological score derived from APACHE II and provides rapid risk stratification using age, mean arterial pressure, respiratory rate, pulse rate, oxygen saturation, and Glasgow Coma Scale. The modified REMS (mREMS) substituting systolic blood pressure for mean arterial pressure, reducing the weighting of age, and increasing the weighting of GCS. It showed an AUROC of 0.967 for predicting in-hospital mortality.

Neurologic status is central to ICU prognosis and risk adjustment, but the Glasgow Coma Scale (GCS) has practical limitations because its verbal component is difficult or impossible to assess in intubated or mechanically ventilated patients. The FOUR score was developed to address this by using eye, motor, brainstem reflexes, and respiration, and it has shown feasibility and reliable use in emergency and intensive care settings. Prior studies suggest FOUR is often at least comparable to GCS for mortality prediction and may perform better in some ICU cohorts, especially when verbal assessment is compromised.

Despite this promise, the available evidence largely evaluates FOUR as a standalone score, not as a direct replacement for GCS inside established ICU severity models. No retrieved studies identified substantive derivation, recalibration, or external validation of FOUR-substituted versions of APACHE, SAPS, MODS, or LODS. The only identified model-level substitution evidence was for SOFA, and it was unfavorable: a FOUR-based modification did not improve mortality prediction and showed lower AUROC than the standard GCS-based SOFA. This leaves a clear methodological gap in whether FOUR can be validly integrated into legacy severity scores rather than only used as an independent neurologic assessment. Accordingly, this study aims to determine whether FOUR can replace GCS in established ICU severity scores and whether such substitution supports the derivation and validation of modified APACHE, SAPS, MODS, LODS, and SOFA models.

02

Conditions studied

  • ICU Mortality (Survival Rate)

Keywords

  • ICU Scoring Systems
  • GCS
  • FOUR Score
  • APACHE
  • SAPS
  • MODS
  • LODS
  • SOFA
03

In context

Multiple Organ Failure

193 studies on the registry are indexed under Multiple Organ Failure; 47 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 200 across 94 observational studies indexed under Multiple Organ Failure.

Browse Multiple Organ Failure studies →

Lead sponsor

Al-Nahrain University is the lead sponsor of 26 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will be drawn from patients admitted to the intensive care unit(s) of a tertiary-care teaching hospital in Baghdad, Iraq, during the predefined study period. The source population will include consecutive ICU admissions managed under routine clinical care, representing a broad spectrum of acute medical, surgical, traumatic, neurological, and other critical illnesses. Routinely collected clinical and physiological data from eligible ICU admissions will be used for the derivation and validation of modified severity-scoring models.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients for whom sufficient clinical and physiological data are available to calculate the original APACHE, SAPS, MODS, LODS, and SOFA scores.
  • Patients with a documented mortality outcome.

Exclusion criteria

Exclusion Criteria:

  • Patients transferred from another hospital after initial resuscitation.
  • Patients who died before the required initial clinical assessment.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. In hospital mortality

    Mortality (death) during hospitalization

    Time frame: In-Hospital Phase (average of 20 days through discharge)

07

Study locations

1 site
08

References and documents

Publications

  • Kramer AA, Wijdicks EF, Snavely VL, Dunivan JR, Naranjo LL, Bible S, Rohs T, Dickess SM. A multicenter prospective study of interobserver agreement using the Full Outline of Unresponsiveness score coma scale in the intensive care unit. Crit Care Med. 2012 Sep;40(9):2671-6. doi: 10.1097/CCM.0b013e318258fd88. PubMed 22732282 ↗
  • Wijdicks EF, Kramer AA, Rohs T Jr, Hanna S, Sadaka F, O'Brien J, Bible S, Dickess SM, Foss M. Comparison of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in predicting mortality in critically ill patients*. Crit Care Med. 2015 Feb;43(2):439-44. doi: 10.1097/CCM.0000000000000707. PubMed 25393699 ↗
  • Ramazani J, Hosseini M. Comparison of full outline of unresponsiveness score and Glasgow Coma Scale in Medical Intensive Care Unit. Ann Card Anaesth. 2019 Apr-Jun;22(2):143-148. doi: 10.4103/aca.ACA_25_18. PubMed 30971594 ↗
  • Telles GP, Ferreira IBB, Carvalho de Menezes R, do Carmo TA, David Pugas PL, Marback LF, Arriaga MB, Fukutani KF, Neto LP, Agareno S, Akrami KM, Filgueiras Filho NM, Andrade BB. Comparison of a modified Sequential Organ Failure Assessment Score using RASS and FOUR. PLoS One. 2020 Feb 21;15(2):e0229199. doi: 10.1371/journal.pone.0229199. eCollection 2020. PubMed 32084199 ↗
  • Ferreira AM, Sakr Y. Organ dysfunction: general approach, epidemiology, and organ failure scores. Semin Respir Crit Care Med. 2011 Oct;32(5):543-51. doi: 10.1055/s-0031-1287862. Epub 2011 Oct 11. PubMed 21989690 ↗
  • Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993 Dec 22-29;270(24):2957-63. doi: 10.1001/jama.270.24.2957. PubMed 8254858 ↗
  • Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985 Oct;13(10):818-29. PubMed 3928249 ↗
  • Pellathy TP, Pinsky MR, Hravnak M. Intensive Care Unit Scoring Systems. Crit Care Nurse. 2021 Aug 1;41(4):54-64. doi: 10.4037/ccn2021613. PubMed 34333619 ↗
  • Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981 Aug;9(8):591-7. doi: 10.1097/00003246-198108000-00008. PubMed 7261642 ↗
  • Momenyan S, Mousavi SM, Dadkhahtehrani T, Sarvi F, Heidarifar R, Kabiri F, Mohebi E, Koohbor M. Predictive Validity and Inter-Rater Reliability of the Persian Version of Full Outline of Unresponsiveness Among Unconscious Patients with Traumatic Brain Injury in an Intensive Care Unit. Neurocrit Care. 2017 Oct;27(2):229-236. doi: 10.1007/s12028-016-0324-0. PubMed 28054286 ↗
  • Chen B, Grothe C, Schaller K. Validation of a new neurological score (FOUR Score) in the assessment of neurosurgical patients with severely impaired consciousness. Acta Neurochir (Wien). 2013 Nov;155(11):2133-9; discussion 2139. doi: 10.1007/s00701-013-1854-2. Epub 2013 Sep 8. PubMed 24013867 ↗
  • Sadaka F, Patel D, Lakshmanan R. The FOUR score predicts outcome in patients after traumatic brain injury. Neurocrit Care. 2012 Feb;16(1):95-101. doi: 10.1007/s12028-011-9617-5. PubMed 21845490 ↗
  • Karna R. Glasgow Coma Scale (GCS) Score and Full Outline of UnResponsiveness (FOUR) Score in Predicting Outcomes in Patients Admitted to the Medical Intensive Care Unit of Patan Hospital. Cureus. 2026 May 11;18(5):e108684. doi: 10.7759/cureus.108684. eCollection 2026 May. PubMed 42291990 ↗
  • Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: The FOUR score. Ann Neurol. 2005 Oct;58(4):585-93. doi: 10.1002/ana.20611. PubMed 16178024 ↗
  • Reith FC, Brennan PM, Maas AI, Teasdale GM. Lack of Standardization in the Use of the Glasgow Coma Scale: Results of International Surveys. J Neurotrauma. 2016 Jan 1;33(1):89-94. doi: 10.1089/neu.2014.3843. Epub 2015 Aug 12. PubMed 25951090 ↗
  • DiGiorgio AM, Wittenberg BA, Crutcher CL 2nd, Kennamer B, Greene CS, Velander AJ, Wilson JD, Tender GC, Culicchia F, Hunt JP. The Impact of Drug and Alcohol Intoxication on Glasgow Coma Scale Assessment in Patients with Traumatic Brain Injury. World Neurosurg. 2020 Mar;135:e664-e670. doi: 10.1016/j.wneu.2019.12.095. Epub 2019 Dec 24. PubMed 31881342 ↗
  • Ali WI, Hakeem LA, Mohammed ZT, Fawzi HA. Study of incidental errors that occur in the intensive care unit of Ghazi Al-Hariri Teaching Hospital. Medicine (Baltimore). 2025 Sep 12;104(37):e44412. doi: 10.1097/MD.0000000000044412. PubMed 40958303 ↗
  • Shumet T, Kebede F. Incidence and Predictors of Inpatient Mortality Rate After Cases Started Care in the Intensive Care Unit in Debre Markos Referral Hospital. Health Serv Res Manag Epidemiol. 2023 Oct 26;10:23333928231208252. doi: 10.1177/23333928231208252. eCollection 2023 Jan-Dec. PubMed 37901610 ↗
  • Capuzzo M, Volta C, Tassinati T, Moreno R, Valentin A, Guidet B, Iapichino G, Martin C, Perneger T, Combescure C, Poncet A, Rhodes A; Working Group on Health Economics of the European Society of Intensive Care Medicine. Hospital mortality of adults admitted to Intensive Care Units in hospitals with and without Intermediate Care Units: a multicentre European cohort study. Crit Care. 2014 Oct 9;18(5):551. doi: 10.1186/s13054-014-0551-8. PubMed 25664865 ↗
  • Andraos C, Siddiqi A, Brazdzionis J, Siddiqi J. Limitations of the Glasgow Coma Scale: Challenges and Considerations. Cureus. 2025 Feb 12;17(2):e78900. doi: 10.7759/cureus.78900. eCollection 2025 Feb. PubMed 40091938 ↗
  • Vincent JL, Marshall JC, Namendys-Silva SA, Francois B, Martin-Loeches I, Lipman J, Reinhart K, Antonelli M, Pickkers P, Njimi H, Jimenez E, Sakr Y; ICON investigators. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014 May;2(5):380-6. doi: 10.1016/S2213-2600(14)70061-X. Epub 2014 Apr 14. PubMed 24740011 ↗
  • Zimmerman JE, Kramer AA. A history of outcome prediction in the ICU. Curr Opin Crit Care. 2014 Oct;20(5):550-6. doi: 10.1097/MCC.0000000000000138. PubMed 25137400 ↗
  • Power GS, Harrison DA. Why try to predict ICU outcomes? Curr Opin Crit Care. 2014 Oct;20(5):544-9. doi: 10.1097/MCC.0000000000000136. PubMed 25159474 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07832773
Lead sponsor
Al-Nahrain University
Responsible party
Abdulillah R. Khamees (Principal Investigator, Al-Nahrain University) — Principal investigator
First posted
Sep 22, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Dec 1, 2027 (estimated)
Completion
Dec 15, 2027 (estimated)
Last update
Sep 22, 2026

Study contacts

Abdulillah R. Khamees, MBBCH
Contact
abdulilah.r.khamis@gmail.com
07838571013

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion